期刊文献+

免疫荧光细胞化学染色联合激光扫描共聚焦显微技术对脑膜癌病的诊断价值 被引量:4

Evaluation of immunofluorescence cytochemical staining and laser-scanning confocal microscopy in the diagnosis of meningeal carcinomatosis
下载PDF
导出
摘要 目的探讨免疫荧光细胞化学染色与激光扫描共聚焦显微技术联合检测在脑膜癌病诊断中的价值。方法采用免疫荧光细胞化学染色法,以小鼠抗人单克隆上皮膜抗原(EMA)标记脑膜癌细胞及对照组脑脊液细胞,激光扫描共聚焦显微技术获得脑膜癌细胞扫描图像并定量检测上皮膜抗原相对荧光强度。结果上皮膜抗原主要表达于脑膜癌细胞的细胞质和细胞膜,着红色荧光,相对荧光强度为(44.84±1 3.05),与对照组(3.98±1.58)相比差异有统计学意义(t=43.954,P=0.001)。免疫荧光细胞化学染色联合激光扫描共聚焦显微技术对上皮膜抗原的检测阳性率为90%(1 8/20),高于常规MGG染色法[60%(12/20)],组间差异具有统计学意义(x^2=4.800,P=0.010)。结论免疫荧光细胞化学染色与激光扫描共聚焦显微技术联合检测脑脊液细胞上皮膜抗原表达变化,可为脑膜癌病的诊断、组织来源提供实验室依据。 Objective To explore the value of combination of immunofluorescence cytochemical staining (ICS) and laser-scanning confocal microscopy (LSCM) in the diagnosis of meningeal carcinomatosis. Methods ICS and LSCM were used to detect the cellular distribution and quantity of epithelial membrane antigen (EMA) in cerebrospinal fluid (CSF) cells of patients with meningeal carcinomatosis (MC group) and controls (control group). Results The EMA was expressed with red fluorescence in the cytoplasm of meningeal carcinomatosis cells. The mean fluorescent intensity of cellular EMA in meningeal carcinomatosis cells of CSF in MC group (44.84 + 13.05) was significantly higher than the cells of CSF in control group (3.98 + 1.58; t = 43.954, P = 0.001). The positive rate of routine cerebrospinal fluid cytologic examination (May-Grunwal-Giemsa staining) and EMA immunofluorescence examination combined LSCM was 60% (12/20) and 90% (18/20), respectively, the difference was significant (X2= 4.800, P = 0.010), Conclusion The combination of immunofluorescence cytochemical staining and LSCM for the detection of EMA expression changes in cells of CSF is useful for the diagnosis and differential diagnosis of meningeal carcinomatosis.
出处 《中国现代神经疾病杂志》 CAS 2011年第5期534-537,共4页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 宁夏自然科学基金资助项目(项目编号:ZN0791)
关键词 脑膜肿瘤 脑脊髓液 肿瘤转移 CA-15-3抗原 显微镜检查 共焦 荧光免疫 测定 Meningeal neoplasms Cerebrospinal fluid Neoplasm metastasis CA- 15- 3Antigen Microscopy, confocal Fluoroimmunoassay
  • 相关文献

参考文献12

  • 1Sulim S,Hφyer M.Meningeal carcinomatosis.Ugeskr Laeger,2005,167:3481-3484.
  • 2Pavlidis N.The diagnostic and therapeutic management of leptomeningeal carcinomatosis.Ann Oncol,2004,15 Suppl 4:285-291.
  • 3王新高,赵性泉,王拥军.提高脑膜癌病的诊断水平[J].疑难病杂志,2004,3(6):321-322. 被引量:9
  • 4邱雯静,杨欢,杨乐,李艺,梁静慧,邓茂林,赵海婷,肖波.脑膜癌病的临床特点及脑脊液检查对其诊断的重要意义[J].卒中与神经疾病,2007,14(4):217-219. 被引量:11
  • 5孙善平,臧益秀,王晓,陈连胜,田斌,孙涛,金广超.乳腺癌患者外周血EMA、EGP-2和CK19的检测及其临床意义[J].山东大学学报(医学版),2008,46(4):395-398. 被引量:1
  • 6Jorda M,Ganjei-Azar P,Nadji M.Cytologic characteristics of meningeal carcinomatosis:increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry.Arch Neurol,1998,55:181-184.
  • 7庄建华,李焰生,倪麟,赵忠新,赵瑛,黄坚.上皮膜抗原免疫细胞化学检查在脑膜癌病中的诊断价值[J].临床神经病学杂志,2005,18(1):54-56. 被引量:10
  • 8Lee SC,Bajcsy P.Feature based registration of fluorescent LSCM imagery using region centroids.Proc SPIE,2005,5747:170-181.
  • 9Martínez JC, Palomino JC, Cabello A, et al. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas: study by double immunofluorescence and laser scanning confocal microscopy.Histopathology,2005,46:184-194.
  • 10Martinez JC,Palomino JC,Samaniego R,et al.Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: high E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.Cancer,2008,113:166-174.

二级参考文献48

共引文献34

同被引文献53

  • 1马静萍.脑膜癌病的临床特征及误诊原因分析[J].中国现代神经疾病杂志,2004,4(5):301-304. 被引量:7
  • 2关鸿志,陈琳,管宇宙,朱以诚,王长华,郭玉璞.脑膜癌病的脑脊液细胞学与临床观察[J].中国神经免疫学和神经病学杂志,2005,12(2):111-113. 被引量:32
  • 3严金柱,贺斌.结核性脑膜炎和脑膜癌病的早期鉴别诊断[J].中国现代神经疾病杂志,2005,5(4):265-268. 被引量:17
  • 4孔凡元,胡庆和,潘月英,刘铭福.脑脊液细胞成分的CT分析[J].中华神经科杂志,1996,29(5):309-311. 被引量:8
  • 5Nagpal S, RiessJ, Wakelee H. Treatment of leptomeningeal spread of NSCLC: a continuing challenge. Curr Treat Options Oncol, 2012,13(4): 491-504.
  • 6Le Rhun E, Massin F, Tu Q, et al. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis. BMC Clin Patbol, 2012, 12: 21.
  • 7Pachmann K, Clement JH, Schneider CP- et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med, 2005, 43(6): 617-627.
  • 8Igawa S, Gohda K, Fukui T, et al. Circulating tumor cells as a prognostic factor in patients with small celllung cancer. Oncol Lett, 2014, 7(5): 1469-1473.
  • 9Yu Y, Chen Z, DongJ, et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer. Transl Oncol, 2013,6(6): 697-702.
  • 10Le Rhun E, Tu Q. De Carvalho Bittencourt M, et al. Detection and quantification of CSF malignant cells by the Cell Search technology in patients with melanoma leptomeningeal metastasis. Med Oncol, 2013, 30(2): 538.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部